Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT06150326 Not yet recruiting - Critical Illness Clinical Trials

Medical Honey for Wound Treatment in Intensive Care. (MICARéa) Randomized, Controlled, Single-center Pilot Study.

MICAREA
Start date: January 2024
Phase: Phase 2/Phase 3
Study type: Interventional

Wound management is a real public health issue in France. To date, a wide range of devices exists to treat these wounds, depending on their nature and stage of evolution. Honey has been proposed for the care of wounds and is effective in reducing the surface of wounds and the pain perceived by patients. Inanition, its use is very simple compared to usual care, requiring different types of dressing accross time. In the intensive care unit, patients are prone to suffering or developing numerous types of wound, but the interest of honey has not been investigated yet. We propose a prospective, monocentric, randomized, single-blind, controlled clinical trial to assess the efficacy of managing acute cutaneous wounds with honey (Activon®) compared with standard care, in intensive care patients. The primary endpoint is the percentage of wound surface area reduction measured at 15 days from inclusion.

NCT ID: NCT06147804 Not yet recruiting - Clinical trials for Urinary Bladder Trauma

Managment and Outcome of Urinary Bladder Trauma After Gynaecological and Obstetric Operations

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

We aimed to evaluate the management and outcome of bladder trauma after gynecological and obstetric operations at Assiut university hospital and to evaluate the methods of treatment of these complications. We aimed to find out risk factors for vesico uterine fistula after bladder trauma

NCT ID: NCT06146062 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived From Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury.

TRAUMACELL
Start date: June 18, 2024
Phase: Phase 2
Study type: Interventional

Traumatic brain injuries (TBI) are one of the leading causes of death and disability worldwide. These patients are burdened by physical, cognitive, and psychosocial deficits, leading to an important economic impact for society. Treatments for TBI patients are limited and none has been shown to provide prolonged and long-term neuroprotective or neurorestorative effects. TBI related disability is linked to the severity of the initial injury but also to the following neuroinflammatory response which may persist long after the initial injury. Moreover, a growing body of evidence suggests a link between TBI-induced neuro-inflammation and neurodegenerative post traumatic disorders. Consequently, new therapies triggering immunomodulation and promoting neurological recovery are the subject of major research efforts. In this context, mesenchymal cell-based therapies are currently investigated to treat various neurological disorders due to their ability to modulate neuroinflammation and to promote simultaneous neurogenesis, angiogenesis, and neuroprotection. Clinical trials using intravenous MSC have been conducted for various pathologies, all these studies showing a good safety profile. The hypothesis of the study is that intravenous repeated treatment with MSC derived from Wharton's Jelly of the umbilical cord may be associated with a significant decrease of post-TBI neuroinflammation and improvement of neuroclinical status. The main objective of the study is to evaluate the effect of iterative IV injections of MSC on post-traumatic neuroinflammation measured in corpus callosum by PET-MRI at 6 months in severe brain injured patients unresponsive to simple verbal commands 5 days after sedation discontinuation.

NCT ID: NCT06128057 Not yet recruiting - Clinical trials for Massive Blood Transfusion in Trauma Patients

Comparing TASH Score and Modified TBSS in Trauma Patients in Need for Massive Blood Transfusion

Start date: December 5, 2023
Phase:
Study type: Observational

Evaluate And Compare predictive value of TASH Score And MTBBS In need for Massive Blood Transfusion

NCT ID: NCT06124105 Not yet recruiting - Sepsis Clinical Trials

Can Urinary Partial Oxygen Pressure be an Indicator of Acute Kidney Injury in Patients With Sepsis?

Start date: March 6, 2024
Phase: N/A
Study type: Interventional

The ability of bladder urinary partial pressure, measured as a reflection of renal medullary oxygen tension, which is an indicator of the development of acute kidney injury (AKI), to predict the development of AKI at an early stage.

NCT ID: NCT06122402 Not yet recruiting - Skin Injury Clinical Trials

Effectiveness of Care Bundle in Preventing Medical Adhesive-Related Skin Injury Due to Central Venous Catheter Fixation in Children

Start date: January 2, 2024
Phase: N/A
Study type: Interventional

Skin injury due to the use of medical adhesives is a common but under recognized complication in children. To prevent central venous catheter-related complications, care interventions should be planned in such a way that they do not lead to medical adhesive-related skin injury. Systematic administration of preventive care interventions is needed to reduce skin injuries associated with medical adhesive used for central venous catheter fixation. The SECURE Care Bundle has been developed by researchers based on the latest evidence to prevent medical adhesive-related skin injuries associated with central venous catheter fixation in children. The SECURE Care Bundle is a systematic approach to care that includes checking the skin, assessing risk factors, correctly applying and removing medical adhesives and registering medical adhesive related skin injury. The goal of this randomized controlled trial study is to evaluate about SECURE care bundle in preventing medical adhesive-related skin injury due to central venous catheter fixation in children. The main questions it aims to answer are 1. Is the SECURE Care Bundle effective in reducing the incidence of medical adhesive-related skin injuries due to central venous catheter fixation? 2. Does the SECURE Care Bundle have an effect on the first central venous catheter dressing change time? Data will collect after the parents of the children who meet the case selection criteria will inform about the research, their oral and written consents will be obtained through the "Informed Consent Form". Researchers will compare the SECURE Care Bundle group to the standard care group to see medical adhesive-related skin injury due to central venous catheter fixation.

NCT ID: NCT06121167 Not yet recruiting - Acute Kidney Injury Clinical Trials

To Examine Whether Urinary Partial Oxygen Pressure Measurements Are Indicative of the Postoperative Occurrence of Acute Kidney Injury (AKI) in Individuals Who Have Undergone Liver Transplantation

Start date: March 6, 2024
Phase:
Study type: Observational

Postoperative acute kidney injury (AKI) is a frequent occurrence among liver transplant recipients and results in considerable mortality and morbidity. The delayed increase in plasma creatinine levels and its susceptibility to external influences, which are utilized in the current diagnostic criteria for AKI, contribute to diagnostic delays. Therefore, numerous biomarkers, including KIM-1, NGAL, TIMP-2, and CYSTATIN C in plasma, along with urine partial oxygen pressure levels and NGAL, are currently under examination to identify acute kidney injury at its early stage. It is well-established that the renal medulla is highly susceptible to hypoxia, which may consequently lead to acute kidney injury. A range of studies have also demonstrated that urine partial oxygen pressure is capable of providing valuable insights into the oxygenation state of the renal medulla. Although urine oxygen pressure measurement is not commonly used, unlike blood gas analysis, urine partial oxygen pressure measurement dates back to 1964. Research among cardiopulmonary bypass patients suggests a correlation between urine partial oxygen pressure data and acute kidney injury. Therefore, we hypothesize that monitoring urine partial oxygen pressure levels may offer insight into the development of acute kidney injury in liver transplant recipients.

NCT ID: NCT06117826 Not yet recruiting - Acute Kidney Injury Clinical Trials

Incidince of Acute Kidney Injury in Children With Community Acquired Pneumonia at Assiut University Children Hospital

Start date: June 30, 2024
Phase:
Study type: Observational

Descriptive prospective observational study of Incidince of acute kidney injury in children with community acquired pneumonia at assiut university children hospital

NCT ID: NCT06114693 Not yet recruiting - Clinical trials for AKI - Acute Kidney Injury

Parameters of the Recovery Time of Acute Kidney Injury in Critically Ill Patients

Start date: January 2024
Phase:
Study type: Observational

the primary objective of this study is to identify and analyze parametrers affecting the time of recovery of AKI in critical ill patient ,Specifically, the study aims to: 1. to identify outcomes of critically ill patients who experienced AKI 2. Examine the relationship between demographic and clinical variables (e.g., age, gender, comorbidities) and outcome of AKI patient 3. follow Baseline characteristics and laboratory findings of the patients at the time of admission to the intensive care unit and affecting it at recovery time 4. Explore the association between psychosocial factors (e.g., depression, anxiety, social support) and outcome of AKI patient at icu

NCT ID: NCT06109844 Not yet recruiting - Venous Leg Ulcer Clinical Trials

FORCEREPAIR - A Wound Exudate Investigation

Start date: January 30, 2024
Phase:
Study type: Observational

The observational longitudinal study will collect wound exudate from twenty patients with venous leg ulcers. Wound exudate samples are collected using twenty-four-hour collection with polyurethane foam, bandages and the NovaSwab method. Each patient is seen four times where wound exudate and the bacteria microbiome are sampled and wound size is monitored with advanced planimetric tools.